BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18092010)

  • 21. Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis.
    Li BH; Zhao P; Liu SZ; Yu YM; Han M; Wen JK
    World J Gastroenterol; 2005 May; 11(20):3046-50. PubMed ID: 15918187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
    Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
    Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma.
    Zhang JF; Zhang YP; Hao FY; Zhang CX; Li YJ; Ji XR
    World J Gastroenterol; 2005 Sep; 11(36):5592-600. PubMed ID: 16237750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
    Graesslin O; Cortez A; Uzan C; Birembaut P; Quereux C; Daraï E
    Int J Gynecol Cancer; 2006; 16(5):1911-7. PubMed ID: 17009991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
    Maeta H; Ohgi S; Terada T
    Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
    Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma].
    Klisho EV; Savenkova OV; Kondakova IV; Perel'muter VM; Choĭnzonov EL; Shishkin DA
    Vopr Onkol; 2007; 53(1):26-31. PubMed ID: 17649730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.
    Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G
    Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of matrix metaloproteinase and tissue inhibitors in ovarian tumors].
    Cai W; Song JD
    Ai Zheng; 2002 Jan; 21(1):91-4. PubMed ID: 12500407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of MMP-3, MMP-13, TIMP-2 and TIMP-3 in the VX2 carcinoma of the New Zealand white rabbit.
    Mandic R; Dünne AA; Eikelkamp N; Ramaswamy A; Schulz S; Teymoortash A; Sesterhenn A; Moll R; Werner JA
    Anticancer Res; 2002; 22(6A):3281-4. PubMed ID: 12530076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].
    Solov'eva NI; Timoshenko OS; Kugaevskaia EV; Andreeva IuIu; Zavalishina LE
    Bioorg Khim; 2014; 40(6):743-51. PubMed ID: 25895371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer.
    Moser PL; Kieback DG; Hefler L; Tempfer C; Neunteufel W; Gitsch G
    Anticancer Res; 1999; 19(5C):4391-3. PubMed ID: 10650781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of basic fibroblast factor (bFGF) on MMP-2, TIMP-2, and type-I collagen levels in human lung carcinoma fibroblasts.
    Nakoman C; Resmi H; Ay O; Acikel U; Atabey N; Güner G
    Biochimie; 2005; 87(3-4):343-51. PubMed ID: 15781321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
    Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
    J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of monocarboxylate transporter 1 inhibits the invasion and migration through suppression of the PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells.
    Zhang P; Ma J; Gao J; Liu F; Sun X; Fang F; Zhao S; Liu H
    J Bioenerg Biomembr; 2018 Aug; 50(4):271-281. PubMed ID: 29882205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients.
    Ben Nasr H; Chahed K; Remadi S; Zakhama A; Chouchane L
    Arch Med Res; 2009 Apr; 40(3):196-203. PubMed ID: 19427971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
    Zheng Y; Ding J; Wang CL; Jiao SS; Qu LM; Bahargul ; Bao H; Chen X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):299-302. PubMed ID: 21624249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.